AUVI - Applied UV secures $7.5M in debt financing
- Applied UV ( NASDAQ: AUVI ) has entered into agreements for $7.5M in debt financing.
- In early Oct, the pathogen elimination technology company announced a securities purchase agreement, whereby a single investor purchased an 18-month $2,807,500 Redeemable Note from the xompany for $2.5M. The note bears interest at a rate of 8% per annum.
- Furthermore, it secured a $5M non-dilutive asset based line of credit from Pinnacle Bank recently.
- The additional working capital will support the company’s growth initiatives, including increasing production at its recently acquired manufacturing facility in Brooklyn, New York.
For further details see:
Applied UV secures $7.5M in debt financing